Wisconsin device-maker Neuwave Medical just raised a $25 million equity round from 38 investors, according to a regulatory filing.
The company has a whole suite of cancer ablation tools, and many of which have received FDA approval. They use microwaves to kill tumor cells – a useful alternative to surgery for some patients, particularly those too ill to undergo the knife.
Its lead product, the Certus 140 Microwave Ablation System, allows microwaves to be administered to a tumor site with a super-thin flexible probe – allowing higher levels of energy to be administered with high site specificity
Help employers find you! Check out all the jobs and post your resume.
